Consortium invests SEK 10m in Promimic

ALMI Invest provided the bulk of the funding from its ALMI Invest Västsverige Fund. The investors were attracted to the deal after a number of successful pre-clinical tests.

Funding will support a more aggressive expansion strategy, with increased international market presence.

Company
Promimic is based in Gothenburg and is a biomaterial company that develops and markets an implant surface which is said to accelerate osseointegration. The company's product, HANANO, is based on nanotechnology.

The company was founded in 2004.

People
Anna Langenius worked on the deal for ALMI Invest.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Healthcare
• Expansion
• Sweden